Abstract Details
|
Brin Freund, MD
PRESENTER |
Dr. Freund has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Freund has received research support from Mayo Clinic. |
| Adrian Safa, MD | Dr. Safa has nothing to disclose. |
| Alina Ivaniuk, MD | Dr. Ivaniuk has nothing to disclose. |
| Anahita Jafari, MD | Dr. Jafari has nothing to disclose. |
| Simidele O. Davis, MHS | Mr. Davis has nothing to disclose. |
| David Sabsevitz | No disclosure on file |
| Anteneh M. Feyissa, MD, MSc, FAAN (Mayo Clinic) | Dr. Feyissa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. |
| Seyed M. Mirsattari, MD, PhD, FRCPC (Mayo Clinic) | Dr. Mirsattari has nothing to disclose. |
| Sanjeet S. Grewal, MD | Sanjeet S. Grewal, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. |
| Kaisorn Chaichana, MD | Dr. Chaichana has nothing to disclose. |
| Alfredo Quinones-Hinojosa | Alfredo Quinones-Hinojosa has nothing to disclose. |
| William O. Tatum IV, DO, FAAN (Mayo Clinic) | Dr. Tatum has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bioserenity. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Defense Law Firm on behalf of a patient with epilepsy with funds donated to the Epilepsy Foundation of America. The institution of Dr. Tatum has received research support from Esai. The institution of Dr. Tatum has received research support from Mayo Clinic. The institution of Dr. Tatum has received research support from Liva Nova. The institution of Dr. Tatum has received research support from Engage Pharmaceuticals. The institution of Dr. Tatum has received research support from Xenon. Dr. Tatum has received intellectual property interests from a discovery or technology relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has a non-compensated relationship as a AAN Section Chair of Clinical Neurophysiology with AAN that is relevant to AAN interests or activities. |